PATH — Malaria Vaccine Trial (2022)

Organization:
PATH
Award Date:
03/2023
Amount:
$1,591,687
Purpose:
To coordinate an efficacy trial measuring the effects of combining the RTS,S malaria vaccine and perennial malaria chemoprevention (PMC).